Just One Small Problem With This Major Report on GMO Safety
By Tom Philpott,
Mother Jones
| 03. 05. 2017
Researchers allege undisclosed conflicts of interest on a National Academies of Sciences panel.
About a year ago, the prestigious National Academies of Sciences, Engineering and Medicine produced a 584-page report assessing the health, environmental, and agronomic impact of genetically modified crops. The conclusion: GMOs have so far proved to be neither a disaster nor a triumph. They haven't been shown to pose a threat to human health, as some critics have argued they do; but they also haven't discernibly raised crop yields, as some boosters insist they have.
Not surprisingly, the report did little to "end the highly polarized dispute over biotech crops," concluded New York Times reporter Andrew Martin in an article just after the report's release. He added that both sides of the debate "pointed approvingly to findings that buttressed their viewpoint and criticized those that did not."
And a new paper, published in the peer-reviewed journal PLOS-One, ups the temperature of that long-simmering debate. The authors—Sheldon Krimsky, a professor in the Department of Urban and Environmental Policy and Planning at Tufts, and Tim Schwab...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...